Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
about
Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives.Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis.Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems.Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
P2860
Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Doxycycline inhibits the cance ...... l transition in breast cancer.
@en
Doxycycline inhibits the cance ...... l transition in breast cancer.
@nl
type
label
Doxycycline inhibits the cance ...... l transition in breast cancer.
@en
Doxycycline inhibits the cance ...... l transition in breast cancer.
@nl
prefLabel
Doxycycline inhibits the cance ...... l transition in breast cancer.
@en
Doxycycline inhibits the cance ...... l transition in breast cancer.
@nl
P2093
P2860
P1433
P1476
Doxycycline inhibits the cance ...... l transition in breast cancer.
@en
P2093
Erina Vlashi
Fengchun Zhang
P2860
P304
P356
10.1080/15384101.2016.1241929
P577
2016-10-18T00:00:00Z